speb/financial-data huggingface dataset:
Financial ratios for TFPM — annual report dated 2025-12-31
Total revenue: 283725547.44525546
Gross profit: 191910948.90510947
Operating income: 158043065.69343063
Net income: 175186131.3868613
Capital expenditures: 158116058.39416057
Operating cash flow: 228344525.54744524
Depreciation & amortization: 58086131.38686131
Net tangible assets: 1492859124.0875912
Owner earnings: 75156204.37956202
Return on net tangible assets (%): 5.034380214911179
Capex to operating income (%): 100.046185323228
Buffett classification: The Gruesome
Stock price: 33.11
P/E ratio: 39.047928464233664
Shares outstanding: 206603912
Book value: 1492859124.0875912
P/B ratio: 4.582251209068964
Market cap (USD): 6840655526.32
Debt to equity: 0.0007153275178135132
Current ratio: 3.9232033275990448
Quick ratio: 3.803425167535369
Effective tax rate (%): 10.897393060536535
Interest coverage ratio: 51.34432060706663
COGS to revenue (%): 32.360356466617276
SG&A to revenue (%): 7.834238906725941
Free cash flow (dilution-adjusted): 68555474.45255473
Buyback yield (%): 0.09617253918832352
Retained earnings: 120401459.85401459
Inventory turnover: 26.963772775991426
Receivables turnover: 15.335910991872485
Capitalized R&D asset: 2650099.6503496505
ROCI (R&D-adjusted, %): 10.296216380958526
Rosenberg metric: 35.01399616279193
FCF margin (%): 24.162601877006665
Revenue growth (%): 50.83312558662383
Rule of 40 score: 74.99572746363049
Financial ratios for TFX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 317.48
Shares outstanding: 44270211
Market cap (USD): 14054906588.28
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TFX — annual report dated 2022-12-31
Total revenue: 2791041000
Gross profit: 1531087000
Operating income: 513520000
Net income: 363139000
Capital expenditures: 79190000
Operating cash flow: 342141000
Depreciation & amortization: 230590000
Net tangible assets: -820927000
Owner earnings: 514539000
Return on net tangible assets (%): -62.6778020457361
Capex to operating income (%): 15.421015734538091
Buffett classification: The Great
Stock price: 242.51
P/E ratio: 29.564351032552274
Shares outstanding: 44270211
Book value: 4021968000
P/B ratio: 2.669332244714528
Market cap (USD): 10735968869.609999
Debt to equity: 0.4554884573920031
Current ratio: 2.426487380737826
Quick ratio: 1.431620727370282
Effective tax rate (%): 18.6139186713282
Interest coverage ratio: 9.463364293085656
COGS to revenue (%): 45.14279797394592
R&D to revenue (%): 5.511169488373692
SG&A to revenue (%): 30.94716272530572
Free cash flow (dilution-adjusted): 235727000
Buyback yield (%): 0
Retained earnings: 3817304000
Inventory turnover: 2.1779408027906317
Receivables turnover: 6.826831917110612
Capitalized R&D asset: 153819000
ROCI (R&D-adjusted, %): 9.4773698193493
FCF margin (%): 8.445845116571201
Rule of 40 score: 8.445845116571201
Financial ratios for TFX — annual report dated 2023-12-31
Total revenue: 1712441000
Gross profit: 1040112000
Operating income: 303745000
Net income: 356328000
Capital expenditures: 46421000
Operating cash flow: 510638000
Depreciation & amortization: 148105000
Net tangible assets: -975027000
Owner earnings: 458012000
Return on net tangible assets (%): -46.974288917127424
Capex to operating income (%): 15.28288531498461
Buffett classification: The Great
Stock price: 243.68
P/E ratio: 30.274817068768105
Shares outstanding: 44270211
Book value: 4440988000
P/B ratio: 2.4291362679836106
Market cap (USD): 10787765016.48
Debt to equity: 0.4337710437407172
Current ratio: 2.319600491145374
Quick ratio: 1.2875095798070029
Effective tax rate (%): 22.586439398025785
Interest coverage ratio: 3.5728821135342415
COGS to revenue (%): 39.261440248160376
R&D to revenue (%): 6.6353818905293664
SG&A to revenue (%): 36.36563245098664
Free cash flow (dilution-adjusted): 436916000
Buyback yield (%): 0
Retained earnings: 4109736000
Inventory turnover: 1.0736375308200365
Receivables turnover: 3.8614846200506463
Capitalized R&D asset: 216685730
ROCI (R&D-adjusted, %): 4.595364972184321
Rosenberg metric: -3.191900870503644
FCF margin (%): 25.51422209582695
Revenue growth (%): -38.64507902248659
Rule of 40 score: -13.130856926659643
Financial ratios for TFX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 242.83
Shares outstanding: 44270211
Market cap (USD): 10750135337.130001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TFX — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 175.06
Shares outstanding: 44270211
Market cap (USD): 7749943137.66
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TFX — annual report dated 2024-12-31
Total revenue: 1699546000
Gross profit: 1037387000
Operating income: 253846000
Net income: 69675000
Capital expenditures: 90437000
Operating cash flow: 635738000
Depreciation & amortization: 161534000
Net tangible assets: 937542000
Owner earnings: 140772000
Return on net tangible assets (%): 15.01500732767172
Capex to operating income (%): 35.626718561647614
Buffett classification: The Good
Stock price: 175.06
P/E ratio: 111.22989792120559
Shares outstanding: 44270211
Book value: 4278140000
P/B ratio: 1.8115216280112385
Market cap (USD): 7749943137.66
Debt to equity: 0.40761382282954745
Current ratio: 2.2654983368239496
Quick ratio: 1.7930854995688061
Effective tax rate (%): -117.53898820844428
Interest coverage ratio: 3.0395986253637157
COGS to revenue (%): 38.96093427303527
R&D to revenue (%): 6.414713105735297
SG&A to revenue (%): 39.68824615514967
Free cash flow (dilution-adjusted): 519341000
Buyback yield (%): 2.580664095819257
Retained earnings: 4115870000
Inventory turnover: 2.1585149592849273
Receivables turnover: 7.495803433995052
Capitalized R&D asset: 235911360
ROCI (R&D-adjusted, %): 3.5511890213460546
Rosenberg metric: -0.02398197611483186
FCF margin (%): 30.557631273292984
Revenue growth (%): -0.7530186441459881
Rule of 40 score: 29.804612629146995
Financial ratios for TFX — quarterly report dated 2025-03-31
Total revenue: 414258000
Gross profit: 255431000
Operating income: 77222000
Net income: 95002000
Capital expenditures: 24132000
Operating cash flow: 73094000
Depreciation & amortization: 38620000
Net tangible assets: -782866000
Owner earnings: 109490000
Return on net tangible assets (%): -13.98579067171138
Capex to operating income (%): 31.25016187096941
Buffett classification: The Good
Stock price: 136.26
P/E ratio: 15.874031470021684
Shares outstanding: 44270211
Book value: 4095164000
P/B ratio: 1.4730201161321013
Market cap (USD): 6032258950.86
Debt to equity: 0.48959748620568067
Current ratio: 2.2768064931817746
Quick ratio: 1.324056936658633
Effective tax rate (%): 10.922367278854828
Interest coverage ratio: 4.165830501159842
COGS to revenue (%): 38.34011654572754
R&D to revenue (%): 6.106098132081939
SG&A to revenue (%): 36.912745197437346
Free cash flow (dilution-adjusted): 42332000
Buyback yield (%): 4.9732613013443325
Retained earnings: 4195628000
Inventory turnover: 0.24663649972359047
Receivables turnover: 0.89179222557333
Capitalized R&D asset: 25295000
ROCI (R&D-adjusted, %): 1.4446493781255711
FCF margin (%): 10.218752564826751
Rule of 40 score: 10.218752564826751
Financial ratios for TFX — quarterly report dated 2025-06-30
Total revenue: 780889000
Gross profit: 431085000
Operating income: 177483000
Net income: 122580000
Capital expenditures: 40507000
Operating cash flow: 7742000
Depreciation & amortization: 94423000
Net tangible assets: -635496000
Owner earnings: 176496000
Return on net tangible assets (%): -27.772952150760982
Capex to operating income (%): 22.82303093817436
Buffett classification: The Great
Stock price: 117.02
P/E ratio: 23.809414800948606
Shares outstanding: 44270211
Book value: 4242868000
P/B ratio: 1.2209901630736568
Market cap (USD): 5180500091.22
Debt to equity: 0.47023640612906176
Current ratio: 2.4071309282438826
Quick ratio: 1.4384959533504247
Effective tax rate (%): 9.362199251733877
Interest coverage ratio: 8.175925925925926
COGS to revenue (%): 44.79561115600297
R&D to revenue (%): 4.932967425588015
SG&A to revenue (%): 27.54309511338999
Free cash flow (dilution-adjusted): -40902000
Buyback yield (%): 0.03656017694527182
Retained earnings: 4303130000
Inventory turnover: 0.5042685018870209
Receivables turnover: 1.5197951780028494
Capitalized R&D asset: 55468650
ROCI (R&D-adjusted, %): 2.9001541453404034
Rosenberg metric: 6.944218224945641
FCF margin (%): -5.23787631788897
Revenue growth (%): 88.50305848046386
Rule of 40 score: 83.26518216257489
Financial ratios for TFX — quarterly report dated 2025-09-30
Total revenue: 913021000
Gross profit: 451642000
Operating income: 112650000
Net income: -408892000
Capital expenditures: 29946000
Operating cash flow: 107634000
Depreciation & amortization: 77925000
Net tangible assets: -1126320000
Owner earnings: -360913000
Capex to operating income (%): 26.583222370173104
Buffett classification: The Good
Stock price: 121.31
Shares outstanding: 44270211
Book value: 3821863000
P/B ratio: 1.4051836228587995
Market cap (USD): 5370419296.41
Debt to equity: 0.7245560607483837
Current ratio: 2.5690804920359156
Quick ratio: 1.5310070850791622
Interest coverage ratio: 3.5378913978832323
COGS to revenue (%): 50.533229794276366
R&D to revenue (%): 6.267982883197648
SG&A to revenue (%): 30.860626425898204
Free cash flow (dilution-adjusted): 69657000
Buyback yield (%): 0
Retained earnings: 3879165000
Inventory turnover: 0.5749521785996897
Receivables turnover: 1.5405684955083252
Capitalized R&D asset: 91384420
ROCI (R&D-adjusted, %): 1.8014568872648
Rosenberg metric: 0.5336569663300538
FCF margin (%): 7.629287825800282
Revenue growth (%): 16.9207147238596
Rule of 40 score: 24.550002549659883
Financial ratios for TFX — quarterly report dated 2025-12-31
Total revenue: -401866000
Gross profit: -151412000
Operating income: -164654000
Net income: -714330000
Capital expenditures: 651000
Operating cash flow: 152207000
Depreciation & amortization: -2662000
Net tangible assets: -704432000
Owner earnings: -717643000
Buffett classification: The Gruesome
Stock price: 121.37
Shares outstanding: 44270211
Book value: 3124768000
P/B ratio: 1.7195118194598766
Market cap (USD): 5373075509.070001
Debt to equity: 0.872275637743346
Current ratio: 2.5436638644875633
Quick ratio: 2.012979872077856
Effective tax rate (%): -14.058189458299077
Interest coverage ratio: -5.853323853537149
Free cash flow (dilution-adjusted): 148659000
Buyback yield (%): 0
Retained earnings: 3149760000
Inventory turnover: -0.6193301104118498
Receivables turnover: -1.1628639140235486
Capitalized R&D asset: 63682690
ROCI (R&D-adjusted, %): -3.0109586717499948
Rosenberg metric: -10.537743761794925
Revenue growth (%): -144.01497884495538
Rule of 40 score: -144.01497884495538
Financial ratios for TFX — annual report dated 2025-12-31
Total revenue: 1992713000
Gross profit: 1120754000
Operating income: 255804000
Net income: -905640000
Capital expenditures: 95236000
Operating cash flow: 340677000
Depreciation & amortization: 177738000
Net tangible assets: -704432000
Owner earnings: -823138000
Capex to operating income (%): 37.23006676987068
Buffett classification: The Good
Stock price: 121.37
Shares outstanding: 44270211
Book value: 3124768000
P/B ratio: 1.7195118194598766
Market cap (USD): 5373075509.070001
Debt to equity: 0.872275637743346
Current ratio: 2.5436638644875633
Quick ratio: 2.012979872077856
Effective tax rate (%): -138.38227507840182
Interest coverage ratio: 2.552348263372679
COGS to revenue (%): 43.757380014081306
R&D to revenue (%): 7.2655219291488535
SG&A to revenue (%): 36.14012655108889
Free cash flow (dilution-adjusted): 219746000
Buyback yield (%): 5.583394454322968
Retained earnings: 3149760000
Inventory turnover: 2.156206184547287
Receivables turnover: 5.766235607654312
Capitalized R&D asset: 255321980
ROCI (R&D-adjusted, %): 4.3180988462959435
Rosenberg metric: 0.7646875372634631
FCF margin (%): 11.027478618345942
Revenue growth (%): 17.249724338146777
Rule of 40 score: 28.27720295649272
Financial ratios for THC — annual report dated 2021-12-31
Net income: 1476000000
Capital expenditures: 0
Owner earnings: 1476000000
Buffett classification: The Gruesome
Stock price: 81.69
P/E ratio: 4.767297784552846
Shares outstanding: 86137000
Market cap (USD): 7036531530
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THC — annual report dated 2022-12-31
Total revenue: 19174000000
Gross profit: 15901000000
Operating income: 2412000000
Net income: 1001000000
Capital expenditures: 552000000
Operating cash flow: 1083000000
Depreciation & amortization: 841000000
Net tangible assets: -10405000000
Owner earnings: 1290000000
Return on net tangible assets (%): -12.397885631907736
Capex to operating income (%): 22.885572139303484
Buffett classification: The Great
Stock price: 48.79
P/E ratio: 4.198425804195804
Shares outstanding: 86137000
Book value: 4608000000
P/B ratio: 0.9120278276909722
Market cap (USD): 4202624230
Debt to equity: 3.2723524305555554
Current ratio: 1.3362377122430742
Quick ratio: 1.2457551385165326
Effective tax rate (%): 25.576208178438662
Interest coverage ratio: 2.710112359550562
COGS to revenue (%): 17.069990612287473
SG&A to revenue (%): 46.124960884531134
Free cash flow (dilution-adjusted): 265000000
Buyback yield (%): 5.948664127889445
Retained earnings: -803000000
Inventory turnover: 8.08148148148148
Receivables turnover: 4.69146072914118
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.634920634920634
FCF margin (%): 1.3820798998643997
Rule of 40 score: 1.3820798998643997
Financial ratios for THC — annual report dated 2023-12-31
Total revenue: 20564000000
Gross profit: 16974000000
Operating income: 2443000000
Net income: 1311000000
Capital expenditures: 680000000
Operating cash flow: 2374000000
Depreciation & amortization: 870000000
Net tangible assets: -10067000000
Owner earnings: 1501000000
Return on net tangible assets (%): -14.910102314492898
Capex to operating income (%): 27.834629553827263
Buffett classification: The Good
Stock price: 75.57
P/E ratio: 4.965196864988558
Shares outstanding: 86137000
Book value: 5508000000
P/B ratio: 1.1818033932461873
Market cap (USD): 6509373089.999999
Debt to equity: 2.723674655047204
Current ratio: 1.505672268907563
Quick ratio: 1.419327731092437
Effective tax rate (%): 18.923933209647494
Interest coverage ratio: 2.7114317425083243
COGS to revenue (%): 17.457693055825715
SG&A to revenue (%): 44.47578292161058
Free cash flow (dilution-adjusted): 1557000000
Buyback yield (%): 3.0724925001955916
Retained earnings: -192000000
Inventory turnover: 8.734793187347933
Receivables turnover: 5.150012521913348
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 10.372792119565217
FCF margin (%): 7.571484147053102
Revenue growth (%): 7.249400229477418
Rule of 40 score: 14.82088437653052
Financial ratios for THC — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 166.2
Shares outstanding: 86137000
Market cap (USD): 14315969399.999998
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THC — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 126.23
Shares outstanding: 86137000
Market cap (USD): 10873073510
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for THC — annual report dated 2024-12-31
Total revenue: 20675000000
Gross profit: 17028000000
Operating income: 2917000000
Net income: 4064000000
Capital expenditures: 4050000000
Operating cash flow: 2047000000
Depreciation & amortization: 818000000
Net tangible assets: -7917000000
Owner earnings: 832000000
Return on net tangible assets (%): -10.50903119868637
Capex to operating income (%): 138.84127528282482
Buffett classification: The Gruesome
Stock price: 126.23
P/E ratio: 2.675461001476378
Shares outstanding: 86137000
Book value: 8547000000
P/B ratio: 1.2721508728208728
Market cap (USD): 10873073510
Debt to equity: 1.5412425412425412
Current ratio: 1.782366589327146
Quick ratio: 1.7020881670533643
Effective tax rate (%): 22.5609756097561
Interest coverage ratio: 3.5314769975786926
COGS to revenue (%): 17.639661426844015
SG&A to revenue (%): 42.568319226118504
Free cash flow (dilution-adjusted): 1049000000
Buyback yield (%): 6.180405194372681
Retained earnings: 3008000000
Inventory turnover: 10.540462427745664
Receivables turnover: 5.719225449515906
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 11.845204255664745
FCF margin (%): 5.0737605804111245
Revenue growth (%): 0.539778253258121
Rule of 40 score: 5.613538833669246
Financial ratios for THC — quarterly report dated 2025-03-31
Total revenue: 5223000000
Gross profit: 4316000000
Operating income: 901000000
Net income: 622000000
Capital expenditures: 162000000
Operating cash flow: 815000000
Depreciation & amortization: 206000000
Net tangible assets: -8005000000
Owner earnings: 666000000
Return on net tangible assets (%): -8.319800124921924
Capex to operating income (%): 17.980022197558267
Buffett classification: The Great
Stock price: 134.5
P/E ratio: 4.656521905144694
Shares outstanding: 86137000
Book value: 8653000000
P/B ratio: 1.3388913093724721
Market cap (USD): 11585426500
Debt to equity: 1.522015485958627
Current ratio: 1.7778027409570882
Quick ratio: 1.7005167378117276
Effective tax rate (%): 18.69281045751634
Interest coverage ratio: 4.416666666666667
COGS to revenue (%): 17.3654987555045
SG&A to revenue (%): 40.57055332184568
Free cash flow (dilution-adjusted): 621000000
Buyback yield (%): 3.0037737497190973
Retained earnings: 3414000000
Inventory turnover: 2.636627906976744
Receivables turnover: 1.370506428758856
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.635116598079561
FCF margin (%): 11.889718552556003
Rule of 40 score: 11.889718552556003
Financial ratios for THC — quarterly report dated 2025-06-30
Total revenue: 5271000000
Gross profit: 4339000000
Operating income: 852000000
Net income: 522000000
Capital expenditures: 190000000
Operating cash flow: 936000000
Depreciation & amortization: 208000000
Net tangible assets: -8558000000
Owner earnings: 540000000
Return on net tangible assets (%): -6.309885487263379
Capex to operating income (%): 22.300469483568076
Buffett classification: The Great
Stock price: 176
P/E ratio: 13.251846153846154
Shares outstanding: 86137000
Book value: 8302000000
P/B ratio: 1.8260794989159237
Market cap (USD): 15160112000
Debt to equity: 1.5869669959046013
Current ratio: 1.7087333177241864
Quick ratio: 1.629594942636385
Effective tax rate (%): 18.69158878504673
Interest coverage ratio: 4.135922330097087
COGS to revenue (%): 17.68165433504079
SG&A to revenue (%): 40.97894137734775
Free cash flow (dilution-adjusted): 723000000
Buyback yield (%): 4.927404230258984
Retained earnings: 3702000000
Inventory turnover: 2.757396449704142
Receivables turnover: 1.4242096730613347
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4878008842312105
FCF margin (%): 13.71656232214001
Revenue growth (%): 0.9190120620333142
Rule of 40 score: 14.635574384173324
Financial ratios for THC — quarterly report dated 2025-09-30
Total revenue: 5289000000
Gross profit: 4358000000
Operating income: 817000000
Net income: 579000000
Capital expenditures: 276000000
Operating cash flow: 1058000000
Depreciation & amortization: 218000000
Net tangible assets: -8492000000
Owner earnings: 521000000
Return on net tangible assets (%): -6.13518605746585
Capex to operating income (%): 33.782129742962056
Buffett classification: The Good
Stock price: 203.04
P/E ratio: 10.150468067324434
Shares outstanding: 86137000
Book value: 8700000000
P/B ratio: 2.0102593655172414
Market cap (USD): 17489256480
Debt to equity: 1.5157471264367817
Current ratio: 1.712719298245614
Quick ratio: 1.6368421052631579
Effective tax rate (%): 18.679775280898877
Interest coverage ratio: 3.966019417475728
COGS to revenue (%): 17.602571374550955
SG&A to revenue (%): 41.671393458120626
Free cash flow (dilution-adjusted): 740000000
Buyback yield (%): 0.5317550240420512
Retained earnings: 4044000000
Inventory turnover: 2.6907514450867054
Receivables turnover: 1.3999470619375332
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.2866682758065813
FCF margin (%): 13.991302703724712
Revenue growth (%): 0.3414911781445646
Rule of 40 score: 14.332793881869277
Financial ratios for THC — annual report dated 2025-12-31
Total revenue: 21310000000
Gross profit: 17530000000
Operating income: 3439000000
Net income: 2367000000
Capital expenditures: 972000000
Operating cash flow: 3540000000
Depreciation & amortization: 863000000
Net tangible assets: -8326000000
Owner earnings: 2258000000
Return on net tangible assets (%): -27.11986548162383
Capex to operating income (%): 28.264030241349232
Buffett classification: The Good
Stock price: 198.72
P/E ratio: 7.231577794676806
Shares outstanding: 86137000
Book value: 8973000000
P/B ratio: 1.9076278435305918
Market cap (USD): 17117144640
Debt to equity: 1.4678479884096736
Current ratio: 1.7586825005601614
Quick ratio: 1.680708043916648
Effective tax rate (%): 15.464285714285714
Interest coverage ratio: 4.188794153471377
COGS to revenue (%): 17.738151102768654
SG&A to revenue (%): 40.84936649460347
Free cash flow (dilution-adjusted): 2426000000
Buyback yield (%): 8.097144875209747
Retained earnings: 4415000000
Inventory turnover: 10.862068965517242
Receivables turnover: 5.527885862516213
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.639248036804949
FCF margin (%): 11.384326607226654
Revenue growth (%): 3.071342200725514
Rule of 40 score: 14.455668807952168
Financial ratios for THC — quarterly report dated 2025-12-31
Total revenue: 5527000000
Gross profit: 4517000000
Operating income: 869000000
Net income: 644000000
Capital expenditures: 344000000
Operating cash flow: 731000000
Depreciation & amortization: 231000000
Net tangible assets: -8326000000
Owner earnings: 531000000
Return on net tangible assets (%): -6.377612298822964
Capex to operating income (%): 39.58573072497123
Buffett classification: The Good
Stock price: 198.72
P/E ratio: 7.231577794676806
Shares outstanding: 86137000
Book value: 8973000000
P/B ratio: 1.9076278435305918
Market cap (USD): 17117144640
Debt to equity: 1.4678479884096736
Current ratio: 1.7586825005601614
Quick ratio: 1.680708043916648
Effective tax rate (%): 5.4331864904552125
Interest coverage ratio: 4.239024390243903
COGS to revenue (%): 18.27392798986792
SG&A to revenue (%): 40.20264157770942
Free cash flow (dilution-adjusted): 342000000
Buyback yield (%): 1.156734982172821
Retained earnings: 4415000000
Inventory turnover: 2.9022988505747125
Receivables turnover: 1.433722438391699
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.4464979773141904
FCF margin (%): 6.187805319341415
Revenue growth (%): 4.499905464170921
Rule of 40 score: 10.687710783512337
Financial ratios for TN8.DE — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 656.784090909091
Shares outstanding: 371621465
Market cap (USD): 244075066052.3296
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TN8.DE — annual report dated 2022-12-31
Total revenue: 44915000000
Gross profit: 18971000000
Operating income: 8507000000
Net income: 6960000000
Capital expenditures: 2219000000
Operating cash flow: 9154000000
Depreciation & amortization: 3381000000
Net tangible assets: -14660000000
Owner earnings: 8122000000
Return on net tangible assets (%): -55.4024556616644
Capex to operating income (%): 26.084401081462328
Buffett classification: The Good
Stock price: 545.5531914893618
P/E ratio: 29.12920635872157
Shares outstanding: 371621465
Book value: 44148000000
P/B ratio: 4.592264117439117
Market cap (USD): 202739276256.70215
Debt to equity: 0.7811905409078554
Current ratio: 1.4831863609641387
Quick ratio: 1.1519694297472076
Effective tax rate (%): 8.972559029993619
Interest coverage ratio: 11.717630853994491
COGS to revenue (%): 57.762440164755645
R&D to revenue (%): 3.2750751419347655
SG&A to revenue (%): 20.022264276967604
Free cash flow (dilution-adjusted): 6604000000
Buyback yield (%): 1.4797330124635018
Retained earnings: 41910000000
Inventory turnover: 4.604898828541001
Receivables turnover: 4.764506205579718
Capitalized R&D asset: 1471000000
ROCI (R&D-adjusted, %): 11.624905552492393
FCF margin (%): 14.703328509406658
Rule of 40 score: 14.703328509406658
Financial ratios for TN8.DE — annual report dated 2023-12-31
Total revenue: 42857000000
Gross profit: 17100000000
Operating income: 7318000000
Net income: 5995000000
Capital expenditures: 1392000000
Operating cash flow: 8406000000
Depreciation & amortization: 3406000000
Net tangible assets: -13955000000
Owner earnings: 8009000000
Return on net tangible assets (%): -57.391615908276606
Capex to operating income (%): 19.021590598524188
Buffett classification: The Great
Stock price: 529.1777777777778
P/E ratio: 32.80297264774349
Shares outstanding: 371621465
Book value: 46842000000
P/B ratio: 4.198237074062214
Market cap (USD): 196653821023.22223
Debt to equity: 0.7454207762264634
Current ratio: 1.7548529831572937
Quick ratio: 1.3917356551527262
Effective tax rate (%): 4.509368053350269
Interest coverage ratio: 5.322181818181818
COGS to revenue (%): 60.09986699955666
R&D to revenue (%): 3.1196770655902184
SG&A to revenue (%): 19.705065683552277
Free cash flow (dilution-adjusted): 6649000000
Buyback yield (%): 1.5255233711658922
Retained earnings: 47364000000
Inventory turnover: 5.062303459119497
Receivables turnover: 4.434706125827814
Capitalized R&D asset: 2322570000
ROCI (R&D-adjusted, %): 8.86868588686342
Rosenberg metric: -1.2719238613188306
FCF margin (%): 15.51438504795016
Revenue growth (%): -4.581988199933207
Rule of 40 score: 10.932396848016953
Financial ratios for TN8.DE — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 606.6777777777778
Shares outstanding: 371621465
Market cap (USD): 225454484560.72223
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TN8.DE — annual report dated 2024-12-31
Total revenue: 42879000000
Gross profit: 17702000000
Operating income: 7717000000
Net income: 6338000000
Capital expenditures: 1343000000
Operating cash flow: 8667000000
Depreciation & amortization: 3108000000
Net tangible assets: -11801000000
Owner earnings: 8103000000
Return on net tangible assets (%): -68.66367257012118
Capex to operating income (%): 17.403135933652976
Buffett classification: The Great
Stock price: 517.8541666666666
P/E ratio: 30.36379363727056
Shares outstanding: 371621465
Book value: 49672000000
P/B ratio: 3.8743300868300214
Market cap (USD): 192445724073.0208
Debt to equity: 0.6296303752617168
Current ratio: 1.6604410441044104
Quick ratio: 1.287053705370537
Effective tax rate (%): 9.336364928236463
Interest coverage ratio: 5.551798561151079
COGS to revenue (%): 58.71638797546584
R&D to revenue (%): 3.2416800764943217
SG&A to revenue (%): 20.04477716364654
Free cash flow (dilution-adjusted): 6966000000
Buyback yield (%): 2.078508119246264
Retained earnings: 53102000000
Inventory turnover: 5.057653676175171
Receivables turnover: 4.454498233949719
Capitalized R&D asset: 2771220000
ROCI (R&D-adjusted, %): 8.88387174060493
Rosenberg metric: 0.450261780104712
FCF margin (%): 16.24571468551039
Revenue growth (%): 0.05133350444501482
Rule of 40 score: 16.297048189955404
Financial ratios for TN8.DE — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 517.8541666666666
Shares outstanding: 371621465
Market cap (USD): 192445724073.0208
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TN8.DE — quarterly report dated 2025-03-31
Total revenue: 10364000000
Gross profit: 4235000000
Operating income: 1815000000
Net income: 1511000000
Capital expenditures: 350000000
Operating cash flow: 723000000
Depreciation & amortization: 705000000
Net tangible assets: -12426000000
Owner earnings: 1866000000
Return on net tangible assets (%): -15.016900048285853
Capex to operating income (%): 19.28374655647383
Buffett classification: The Great
Stock price: 493.83695652173907
P/E ratio: 30.364065726960614
Shares outstanding: 371621465
Book value: 49485000000
P/B ratio: 3.7086069163130233
Market cap (USD): 183520413253.74997
Debt to equity: 0.690896231181166
Current ratio: 1.7745559435251252
Quick ratio: 1.3780173068164567
Effective tax rate (%): 5.864197530864197
Interest coverage ratio: 5.99009900990099
COGS to revenue (%): 59.13739868776534
R&D to revenue (%): 3.299884214588962
SG&A to revenue (%): 20.050173678116558
Free cash flow (dilution-adjusted): 286000000
Buyback yield (%): 1.0897970228710419
Retained earnings: 54447000000
Inventory turnover: 1.173238897396631
Receivables turnover: 1.0552896853680889
Capitalized R&D asset: 342000000
ROCI (R&D-adjusted, %): 2.3698221763388974
FCF margin (%): 2.7595522964106523
Rule of 40 score: 2.7595522964106523
Financial ratios for TN8.DE — quarterly report dated 2025-06-30
Total revenue: 10854000000
Gross profit: 4408000000
Operating income: 1916000000
Net income: 1618000000
Capital expenditures: 293000000
Operating cash flow: 1399000000
Depreciation & amortization: 686000000
Net tangible assets: -11886000000
Owner earnings: 2011000000
Return on net tangible assets (%): -16.919064445566214
Capex to operating income (%): 15.292275574112734
Buffett classification: The Great
Stock price: 407.40000000000003
P/E ratio: 48.3856135637584
Shares outstanding: 371621465
Book value: 50602000000
P/B ratio: 2.991948635251571
Market cap (USD): 151398584841
Debt to equity: 0.6961977787439232
Current ratio: 1.9330083346438118
Quick ratio: 1.4959113068092467
Effective tax rate (%): 5.3832650672908136
Interest coverage ratio: 4.742574257425742
COGS to revenue (%): 59.38824396535839
R&D to revenue (%): 3.2430440390639395
SG&A to revenue (%): 19.716233646581905
Free cash flow (dilution-adjusted): 1024000000
Buyback yield (%): 0
Retained earnings: 55901000000
Inventory turnover: 1.159561072135276
Receivables turnover: 1.0816143497757849
Capitalized R&D asset: 581140000
ROCI (R&D-adjusted, %): 2.2859971785332367
Rosenberg metric: 0.5058479532163743
FCF margin (%): 9.43430993182237
Revenue growth (%): 4.727904284060208
Rule of 40 score: 14.162214215882578
Financial ratios for TN8.DE — quarterly report dated 2025-09-30
Total revenue: 11122000000
Gross profit: 4583000000
Operating income: 2075000000
Net income: 1621000000
Capital expenditures: 400000000
Operating cash flow: 2239000000
Depreciation & amortization: 661000000
Net tangible assets: -14511000000
Owner earnings: 1882000000
Return on net tangible assets (%): -12.96947143546275
Capex to operating income (%): 19.27710843373494
Buffett classification: The Great
Stock price: 467.7529411764706
P/E ratio: 36.59516489643344
Shares outstanding: 371621465
Book value: 51154000000
P/B ratio: 3.3981122347823987
Market cap (USD): 173827033258.0588
Debt to equity: 0.6975016616491378
Current ratio: 1.497514777001612
Quick ratio: 1.1116335303600215
Effective tax rate (%): 11.336254107338444
Interest coverage ratio: 5.979827089337176
COGS to revenue (%): 58.793382485164535
R&D to revenue (%): 3.110951267757598
SG&A to revenue (%): 19.438949829167417
Free cash flow (dilution-adjusted): 1765000000
Buyback yield (%): 0.5539989850545035
Retained earnings: 57354000000
Inventory turnover: 1.138207136640557
Receivables turnover: 1.0561200265881683
Capitalized R&D asset: 694700000
ROCI (R&D-adjusted, %): 2.3352588054417573
Rosenberg metric: 0.4971590909090909
FCF margin (%): 15.869447941017803
Revenue growth (%): 2.4691358024691357
Rule of 40 score: 18.33858374348694
Financial ratios for TN8.DE — quarterly report dated 2025-12-31
Total revenue: 12215000000
Gross profit: 5011000000
Operating income: 2303000000
Net income: 1970000000
Capital expenditures: 438000000
Operating cash flow: 3457000000
Depreciation & amortization: 728000000
Net tangible assets: -11793000000
Owner earnings: 2260000000
Return on net tangible assets (%): -19.16391079453913
Capex to operating income (%): 19.018671298306554
Buffett classification: The Great
Stock price: 579.7882352941176
P/E ratio: 32.062760921095936
Shares outstanding: 371621465
Book value: 53536000000
P/B ratio: 4.024614341560159
Market cap (USD): 215461753389.76468
Debt to equity: 0.7356731918708906
Current ratio: 1.8899861742050168
Quick ratio: 1.5328198038053855
Effective tax rate (%): 7.106363214119833
Interest coverage ratio: 6.30958904109589
COGS to revenue (%): 58.97666803110929
R&D to revenue (%): 2.9144494474007367
SG&A to revenue (%): 19.255014326647565
Free cash flow (dilution-adjusted): 2908000000
Buyback yield (%): 0.017172421284935877
Retained earnings: 59156000000
Inventory turnover: 1.327926267281106
Receivables turnover: 1.1560666288093886
Capitalized R&D asset: 703980000
ROCI (R&D-adjusted, %): 2.4073808635093985
Rosenberg metric: 1.2369942196531791
FCF margin (%): 23.806794924273433
Revenue growth (%): 9.827369178205359
Rule of 40 score: 33.63416410247879
Financial ratios for TN8.DE — annual report dated 2025-12-31
Total revenue: 44557000000
Gross profit: 18239000000
Operating income: 8110000000
Net income: 6721000000
Capital expenditures: 1481000000
Operating cash flow: 7818000000
Depreciation & amortization: 2780000000
Net tangible assets: -11793000000
Owner earnings: 8020000000
Return on net tangible assets (%): -68.00644450097515
Capex to operating income (%): 18.261405672009865
Buffett classification: The Great
Stock price: 579.7882352941176
P/E ratio: 32.05799038681218
Shares outstanding: 371621465
Book value: 53536000000
P/B ratio: 4.024614341560159
Market cap (USD): 215461753389.76468
Debt to equity: 0.7356731918708906
Current ratio: 1.8899861742050168
Quick ratio: 1.5328198038053855
Effective tax rate (%): 7.484948002189381
Interest coverage ratio: 5.715292459478506
COGS to revenue (%): 59.06591556882196
R&D to revenue (%): 3.1353098278609424
SG&A to revenue (%): 19.597369661332674
Free cash flow (dilution-adjusted): 5983000000
Buyback yield (%): 1.3923584825623685
Retained earnings: 59156000000
Inventory turnover: 4.851244239631336
Receivables turnover: 4.217016846488738
Capitalized R&D asset: 2769510000
ROCI (R&D-adjusted, %): 8.304781286264488
Rosenberg metric: 0.38633093525179857
FCF margin (%): 13.42774423771798
Revenue growth (%): 3.9133375311924254
Rule of 40 score: 17.341081768910406
Financial ratios for TTD — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 91.64
Shares outstanding: 426999732
Market cap (USD): 39130255440.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TTD — annual report dated 2022-12-31
Total revenue: 1577795000
Gross profit: 1296672000
Operating income: 113654000
Net income: 53385000
Capital expenditures: 84160000
Operating cash flow: 548734000
Depreciation & amortization: 54425000
Net tangible assets: 2096795000
Owner earnings: 23650000
Return on net tangible assets (%): 1.127911884566684
Capex to operating income (%): 74.04930754746863
Buffett classification: The Good
Stock price: 44.83
P/E ratio: 358.57259502781676
Shares outstanding: 426999732
Book value: 2115339000
P/B ratio: 9.049328729607877
Market cap (USD): 19142397985.559998
Debt to equity: 0.12336415108878529
Current ratio: 1.8950245968729473
Quick ratio: 1.8950245968729473
Effective tax rate (%): 58.08667661144696
COGS to revenue (%): 17.817460443213474
R&D to revenue (%): 20.2736096894717
SG&A to revenue (%): 54.70558596015324
Free cash flow (dilution-adjusted): -41793000
Buyback yield (%): 0
Retained earnings: 665514000
Receivables turnover: 0.6722044823715115
Capitalized R&D asset: 319876000
ROCI (R&D-adjusted, %): 12.237973589215265
FCF margin (%): -2.648823199465076
Rule of 40 score: -2.648823199465076
Financial ratios for TTD — annual report dated 2023-12-31
Total revenue: 1946120000
Gross profit: 1580522000
Operating income: 200480000
Net income: 178940000
Capital expenditures: 46790000
Operating cash flow: 598322000
Depreciation & amortization: 80418000
Net tangible assets: 2147318000
Owner earnings: 212568000
Return on net tangible assets (%): 9.899232437859693
Capex to operating income (%): 23.33898643256185
Buffett classification: The Great
Stock price: 71.96
P/E ratio: 171.71622172080026
Shares outstanding: 426999732
Book value: 2164219000
P/B ratio: 14.197685499813096
Market cap (USD): 30726900714.719997
Debt to equity: 0.10899682518266404
Current ratio: 1.718133149171711
Quick ratio: 1.718133149171711
Effective tax rate (%): 33.23009757644732
COGS to revenue (%): 18.78599469714098
R&D to revenue (%): 21.159743489610097
SG&A to revenue (%): 49.75273878280887
Free cash flow (dilution-adjusted): 51681000
Buyback yield (%): 2.104335240326539
Retained earnings: 196954000
Receivables turnover: 0.6780166483585588
Capitalized R&D asset: 626110920
ROCI (R&D-adjusted, %): 12.263279464793925
Rosenberg metric: 0.8873751078542935
FCF margin (%): 2.6555916387478677
Revenue growth (%): 23.34428743911598
Rule of 40 score: 25.99987907786385
Financial ratios for TTD — annual report dated 2024-12-31
Total revenue: 2444831000
Gross profit: 1972819000
Operating income: 427167000
Net income: 393076000
Capital expenditures: 98238000
Operating cash flow: 739456000
Depreciation & amortization: 87490000
Net tangible assets: 2934524000
Owner earnings: 382328000
Return on net tangible assets (%): 13.028620655343081
Capex to operating income (%): 22.997563013996867
Buffett classification: The Great
Stock price: 117.53
P/E ratio: 127.67321968769399
Shares outstanding: 426999732
Book value: 2949145000
P/B ratio: 17.016890828345165
Market cap (USD): 50185278501.96
Debt to equity: 0.10586627649708645
Current ratio: 1.8571508614164431
Quick ratio: 1.8571508614164431
Effective tax rate (%): 22.5163709190975
COGS to revenue (%): 19.30652875393023
R&D to revenue (%): 18.95096225465073
SG&A to revenue (%): 44.27025835323587
Free cash flow (dilution-adjusted): 137695000
Buyback yield (%): 0.4678344068387115
Retained earnings: 354249000
Receivables turnover: 0.734107868168534
Capitalized R&D asset: 844780060
ROCI (R&D-adjusted, %): 12.053006737781208
Rosenberg metric: 0.9526535112216302
FCF margin (%): 5.632086635027124
Revenue growth (%): 25.625912071198076
Rule of 40 score: 31.2579987062252
Financial ratios for TTD — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 117.53
Shares outstanding: 426999732
Market cap (USD): 50185278501.96
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for TTD — quarterly report dated 2025-03-31
Total revenue: 616021000
Gross profit: 473182000
Operating income: 54452000
Net income: 50678000
Capital expenditures: 59113000
Operating cash flow: 291433000
Depreciation & amortization: 23985000
Net tangible assets: 2716684000
Owner earnings: 15550000
Return on net tangible assets (%): 0.5723889859843839
Capex to operating income (%): 108.559832513039
Buffett classification: The Gruesome
Stock price: 54.72
P/E ratio: 115.26414487075259
Shares outstanding: 426999732
Book value: 2716684000
P/B ratio: 8.600715186249118
Market cap (USD): 23365425335.04
Debt to equity: 0.12330031759306566
Current ratio: 1.8106721619410737
Quick ratio: 1.8106721619410737
Effective tax rate (%): 33.115126238963164
Interest coverage ratio: 144.81914893617022
COGS to revenue (%): 23.18735887250597
R&D to revenue (%): 21.493098449565842
SG&A to revenue (%): 46.480233628399034
Free cash flow (dilution-adjusted): 101407000
Buyback yield (%): 1.6530835388678309
Retained earnings: 4518000
Receivables turnover: 0.2018465048978875
Capitalized R&D asset: 132402000
ROCI (R&D-adjusted, %): 4.522493797890284
FCF margin (%): 16.461614133284417
Rule of 40 score: 16.461614133284417
Financial ratios for TTD — quarterly report dated 2025-06-30
Total revenue: 694039000
Gross profit: 543059000
Operating income: 116777000
Net income: 90129000
Capital expenditures: 45239000
Operating cash flow: 165013000
Depreciation & amortization: 26704000
Net tangible assets: 2695833000
Owner earnings: 71594000
Return on net tangible assets (%): 2.6557283036449215
Capex to operating income (%): 38.73964907473218
Buffett classification: The Good
Stock price: 71.99
P/E ratio: 85.26587088140332
Shares outstanding: 426999732
Book value: 2695833000
P/B ratio: 11.402676169733065
Market cap (USD): 30739710706.679996
Debt to equity: 0.12743704821478186
Current ratio: 1.713713943514105
Quick ratio: 1.713713943514105
Effective tax rate (%): 32.33609357287107
COGS to revenue (%): 21.753820750707092
R&D to revenue (%): 19.343437472533964
SG&A to revenue (%): 42.07703025334311
Free cash flow (dilution-adjusted): -12190000
Buyback yield (%): 0.8485538542928338
Retained earnings: -162356000
Receivables turnover: 0.21322845376889302
Capitalized R&D asset: 222960340
ROCI (R&D-adjusted, %): 5.017154594391059
Rosenberg metric: 0.5277639310584432
FCF margin (%): -1.756385448080007
Revenue growth (%): 12.66482798476026
Rule of 40 score: 10.908442536680253
Financial ratios for TTD — quarterly report dated 2025-09-30
Total revenue: 739433000
Gross profit: 577279000
Operating income: 161219000
Net income: 115547000
Capital expenditures: 66336000
Operating cash flow: 224686000
Depreciation & amortization: 33135000
Net tangible assets: 2600786000
Owner earnings: 82346000
Return on net tangible assets (%): 3.166196680541959
Capex to operating income (%): 41.146514988928104
Buffett classification: The Good
Stock price: 49.01
P/E ratio: 81.6342123209312
Shares outstanding: 426999732
Book value: 2600786000
P/B ratio: 8.046512425597491
Market cap (USD): 20927256865.32
Debt to equity: 0.1445628360041926
Current ratio: 1.7097420804462178
Quick ratio: 1.7097420804462178
Effective tax rate (%): 35.63522524078231
COGS to revenue (%): 21.92950544538856
R&D to revenue (%): 17.296090382766256
SG&A to revenue (%): 38.97134696449847
Free cash flow (dilution-adjusted): 33680000
Buyback yield (%): 1.4834576839091755
Retained earnings: -364445000
Receivables turnover: 0.2125822734880854
Capitalized R&D asset: 261533830
ROCI (R&D-adjusted, %): 4.913895111702687
Rosenberg metric: 0.25489568047910255
FCF margin (%): 4.554841344651916
Revenue growth (%): 6.540554637419511
Rule of 40 score: 11.095395982071427
Financial ratios for TTD — annual report dated 2025-12-31
Total revenue: 2896284000
Gross profit: 2277217000
Operating income: 589321000
Net income: 443304000
Capital expenditures: 197011000
Operating cash flow: 992721000
Depreciation & amortization: 115784000
Net tangible assets: 2464462000
Owner earnings: 362077000
Return on net tangible assets (%): 14.69192870492627
Capex to operating income (%): 33.430167939034924
Buffett classification: The Good
Stock price: 37.96
P/E ratio: 36.56387000054139
Shares outstanding: 426999732
Book value: 2484391000
P/B ratio: 6.52429904420037
Market cap (USD): 16208909826.720001
Debt to equity: 0.1756285544425173
Current ratio: 1.6108416511099062
Quick ratio: 1.6108416511099062
Effective tax rate (%): 32.705785914338406
COGS to revenue (%): 21.374526807453964
R&D to revenue (%): 18.1315437298276
SG&A to revenue (%): 40.14644282121505
Free cash flow (dilution-adjusted): 292331000
Buyback yield (%): 8.516439506156097
Retained earnings: -590912000
Receivables turnover: 0.76820556183581
Capitalized R&D asset: 971456750
ROCI (R&D-adjusted, %): 16.785810397109703
Rosenberg metric: 0.6569944250073924
FCF margin (%): 10.093312672376053
Revenue growth (%): 18.465611733489965
Rule of 40 score: 28.558924405866016
Financial ratios for TTD — quarterly report dated 2025-12-31
Total revenue: 846791000
Gross profit: 683697000
Operating income: 256873000
Net income: 186950000
Capital expenditures: 26323000
Operating cash flow: 311589000
Depreciation & amortization: 31960000
Net tangible assets: 2464462000
Owner earnings: 192587000
Return on net tangible assets (%): 7.814565613103388
Capex to operating income (%): 10.247476379378135
Buffett classification: The Great
Stock price: 37.96
P/E ratio: 36.56387000054139
Shares outstanding: 426999732
Book value: 2484391000
P/B ratio: 6.52429904420037
Market cap (USD): 16208909826.720001
Debt to equity: 0.1756285544425173
Current ratio: 1.6108416511099062
Quick ratio: 1.6108416511099062
Effective tax rate (%): 30.827407073031754
COGS to revenue (%): 19.26024249194902
R&D to revenue (%): 15.422341522288264
SG&A to revenue (%): 34.98253996558773
Free cash flow (dilution-adjusted): 169434000
Buyback yield (%): 2.6089478226530023
Retained earnings: -590912000
Receivables turnover: 0.224601439607617
Capitalized R&D asset: 260586140
ROCI (R&D-adjusted, %): 8.150271779184171
Rosenberg metric: 0.8320861970553509
FCF margin (%): 20.008951441382823
Revenue growth (%): 14.518962502349773
Rule of 40 score: 34.5279139437326
Financial ratios for VEA.AX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.347826086956522
Shares outstanding: 1642520936
Market cap (USD): 2213832565.913044
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for VEA.AX — annual report dated 2022-12-31
Total revenue: 17700337837.837837
Gross profit: 1472702702.7027028
Operating income: 402027027.027027
Net income: 347500000
Capital expenditures: 197162162.16216215
Depreciation & amortization: 273108108.1081081
Net tangible assets: 1190000000
Owner earnings: 423445945.94594586
Return on net tangible assets (%): 35.5836929366341
Capex to operating income (%): 49.042016806722685
Buffett classification: The Good
Stock price: 1.554054054054054
P/E ratio: 7.345514588372544
Shares outstanding: 1642520936
Book value: 1595135135.1351352
P/B ratio: 1.6002194818705522
Market cap (USD): 2552566319.4594593
Debt to equity: 1.0405371060657405
Current ratio: 1.0374499866631102
Quick ratio: 0.6209922646038943
Effective tax rate (%): 29.72123531019404
Interest coverage ratio: 16.168478260869566
COGS to revenue (%): 91.67980455404349
SG&A to revenue (%): 3.9986257706182124
Free cash flow (dilution-adjusted): 542094594.5945946
Buyback yield (%): 0.12441109370855322
Retained earnings: 1572027027.0270271
Inventory turnover: 15.382629859732274
Receivables turnover: 13.086472175042461
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.20612973372174
FCF margin (%): 3.0626228694672952
Rule of 40 score: 3.0626228694672952
Financial ratios for VEA.AX — annual report dated 2023-12-31
Total revenue: 17544794520.547947
Gross profit: 839109589.0410959
Operating income: -604041095.890411
Net income: 2602739.7260273974
Capital expenditures: 321917808.2191781
Depreciation & amortization: 304246575.34246576
Net tangible assets: 1012945205.4794521
Owner earnings: -15068493.150684953
Return on net tangible assets (%): -1.4875921292852816
Buffett classification: The Gruesome
Stock price: 2.164383561643836
P/E ratio: 1365.8858309894738
Shares outstanding: 1642520936
Book value: 1377123287.6712332
P/B ratio: 2.5815011229284788
Market cap (USD): 3555045313.534247
Debt to equity: 1.4897543021983486
Current ratio: 1.0011163964663623
Quick ratio: 0.5647509950490244
Effective tax rate (%): 89.64577656675749
Interest coverage ratio: -10.820858895705522
COGS to revenue (%): 95.21733019980168
SG&A to revenue (%): 4.0936311749962915
Free cash flow (dilution-adjusted): 127602739.7260274
Buyback yield (%): 0.33330981811630295
Retained earnings: 1365684931.5068493
Inventory turnover: 13.56523915461624
Receivables turnover: 12.939031166338335
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -17.77343356375582
FCF margin (%): 0.727296860482366
Revenue growth (%): -0.8787590311264393
Rule of 40 score: -0.1514621706440733